Advances in DNA/RNA chromatography columns led to stable, pure mRNA production, supporting the development of COVID-19 vaccines rapidly.
Feature|Videos|April 17, 2026
The SK pharmteco Three-Business-Unit Strategy: Small Molecules, Peptides, and Viral Vectors
Author(s)Joerg Ahlgrimm, SK pharmteco
Key Takeaways
- SK pharmteco is a global CDMO, with locations in the US, EU, and South Korea.
- The company’s core capabilities center on small molecules, peptides, and viral vectors.
Joerg Ahlgrimm, CEO of SK pharmteco, outlines the company's strategic expansion into cell and gene therapy. He also details their commitment to global operational excellence and a culture of employee purpose.
SK pharmteco is doubling down on its growth by injecting $100 million into its cell and gene therapy division to complement its established strengths in small molecules and peptides. CEO Joerg Ahlgrimm stresses that the company’s competitive edge lies not just in its global manufacturing footprint across the US, Europe, and Asia, but in a decentralized culture that empowers frontline employees to connect their daily work directly to patient outcomes. Looking toward the next decade, the discussion explores how the integration of AI and a shift toward regionalized supply chains will redefine the CDMO landscape, positioning the firm as a multi-modal leader in an increasingly complex market.
Related to this article
Steven Ray Wilson's AFFL LC–MS system runs thousands of injections per column, but he calls validation and standardization the field's real barrier.
Kinjal Bhatt and Ina Varfaj describe imposter syndrome fading through repeated exposure and conference talk rather than a single breakthrough moment.
Mass spectrometry can teach core chemistry concepts beyond technique training or product characterization, though adoption barriers remain.
Automated sequential tube sampling and chemometrics supplement GC–MS, adding time profiling and fast product-line comparison for real-world insight.
Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.
Revisiting insertion distance for methanol and methylene chloride in GC analysis and confirming that insertion depth strongly affects response and reproducibility.
SFC Europe 2026 brings global experts to Basel for courses, scientific talks, workshops, and insights into greener separation technologies.